Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Kalydeco (Ivacaftor) – Treatment for Cystic Fibrosis

Drug (Brand / Generic)

Kalydeco / Ivacaftor / VX-770

Company / Licensee

Vertex Pharmaceuticals

Therapy Class

Cystic fibrosis transmembrane conductance regulator

Product Description

Cystic fibrosis transmembrane conductance regulator

Current Indication

Cystic fibrosis

Market Sector

Respiratory

Development Status

Approved in the US
Expand
Close
Close
Close

Go Top